James Tartaglia
Publications by Year
Research Areas
HIV Research and Treatment, Virus-based gene therapy research, Immunotherapy and Immune Responses, Poxvirus research and outbreaks, Herpesvirus Infections and Treatments
Most-Cited Works
- → NYVAC: A highly attenuated strain of vaccinia virus(1992)471 cited
- → Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination(2014)452 cited
- → Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2(2013)384 cited
- → An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses(2008)293 cited
- → Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials(2012)283 cited
- → Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon(1991)238 cited
- → The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer(2005)233 cited
- → Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial(2013)232 cited
- → TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR.(1994)218 cited
- → Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene(1995)195 cited